Hypertension (Dallas, Tex. : 1979)

publication venue for

Risk of Major Adverse Cardiovascular Events After Emergency Department Visits for Hypertensive Urgency. 2024
Social Determinants of Health and Uncontrolled Blood Pressure in a National Cohort of Black and White US Adults: the REGARDS Study. 2023
High Lead Exposure Associated With Higher Blood Pressure in Haiti: a Warning Sign for Low-Income Countries.. 79. 2021
Multiple Social Vulnerabilities to Health Disparities and Hypertension and Death in the REGARDS Study. 2021
Medication Adherence and Blood Pressure Control: A Scientific Statement From the American Heart Association.. 79. 2021
Endothelium-Macrophage Crosstalk Mediates Blood-Brain Barrier Dysfunction in Hypertension.. 76. 2020
Endothelial Sphingolipid De Novo Synthesis Controls Blood Pressure by Regulating Signal Transduction and NO via Ceramide.. 75. 2020
Severity of Hypertension Mediates the Association of Hyperuricemia With Stroke in the REGARDS Case Cohort Study.. 75. 2019
Pulse Wave Velocities Derived From Cuff Ambulatory Pulse Wave Analysis.. 74. 2019
Blood Pressure and Cognitive Decline Over 8 Years in Middle-Aged and Older Black and White Americans.. 73. 2019
Different Relationship Between Systolic Blood Pressure and Cerebral Perfusion in Subjects With and Without Hypertension.. 73. 2019
Renin-Angiotensin-Aldosterone Profiles in Pregnant Women With Chronic Hypertension.. 72. 2018
Selective Nanoparticle Targeting of the Renal Tubules.. 71. 2017
Left Ventricular Mass, Brain Magnetic Resonance Imaging, and Cognitive Performance: Results From the Strong Heart Study.. 70. 2017
Hypertension and VEGF (Vascular Endothelial Growth Factor) Receptor Tyrosine Kinase Inhibition: Effects on Renal Function. 2017
Blood Pressure, Antihypertensive Polypharmacy, Frailty, and Risk for Serious Fall Injuries Among Older Treated Adults With Hypertension.. 70. 2017
Protective Low-Frequency Variants for Preeclampsia in the Fms Related Tyrosine Kinase 1 Gene in the Finnish Population.. 70. 2017
Relationship of Hypertension to Coronary Atherosclerosis and Cardiac Events in Patients With Coronary Computed Tomographic Angiography.. 70. 2017
S1PR1 (Sphingosine-1-Phosphate Receptor 1) Signaling Regulates Blood Flow and Pressure.. 70. 2017
Development of Left Ventricular Hypertrophy in Treated Hypertensive Outpatients: The Campania Salute Network.. 69. 2016
Rnd3/RhoE Modulates Hypoxia-Inducible Factor 1α/Vascular Endothelial Growth Factor Signaling by Stabilizing Hypoxia-Inducible Factor 1α and Regulates Responsive Cardiac Angiogenesis.. 67. 2016
Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Diabetes Mellitus: Action to Control Cardiovascular Risk in Diabetes Blood Pressure Trial.. 66. 2015
Left Ventricular Wall Stress-Mass-Heart Rate Product and Cardiovascular Events in Treated Hypertensive Patients: LIFE Study.. 66. 2015
Effect of lower on-treatment systolic blood pressure on the risk of atrial fibrillation in hypertensive patients.. 66. 2015
Metabolomic identification of a novel pathway of blood pressure regulation involving hexadecanedioate.. 66. 2015
Gut dysbiosis is linked to hypertension.. 65. 2015
Transcription factor avian erythroblastosis virus E26 oncogen homolog-1 is a novel mediator of renal injury in salt-sensitive hypertension.. 65. 2015
Healthy lifestyle factors and risk of cardiovascular events and mortality in treatment-resistant hypertension: the Reasons for Geographic and Racial Differences in Stroke study.. 64. 2014
Hypertension and dementia.. 64. 2014
Altered inflammatory response is associated with an impaired autonomic input to the bone marrow in the spontaneously hypertensive rat.. 63. 2013
Tight versus standard blood pressure control in patients with hypertension with and without cardiovascular disease.. 63. 2013
Refractory hypertension: determination of prevalence, risk factors, and comorbidities in a large, population-based cohort.. 63. 2013
Are observational studies more informative than randomized controlled trials in hypertension? Pro side of the argument.. 62. 2013
Circulating endothelin-1 alters critical mechanisms regulating cerebral microcirculation.. 62. 2013
Hypoxia-inducible factor-1α in vascular smooth muscle regulates blood pressure homeostasis through a peroxisome proliferator-activated receptor-γ-angiotensin II receptor type 1 axis.. 62. 2013
Relationship of left ventricular hypertrophy and diastolic function with cardiovascular and renal outcomes in African Americans with hypertensive chronic kidney disease.. 62. 2013
HO-1 induction improves the type-1 cardiorenal syndrome in mice with impaired angiotensin II-induced lymphocyte activation.. 62. 2013
A trial of 2 strategies to reduce nocturnal blood pressure in blacks with chronic kidney disease.. 61. 2012
Role of the transcription factor erythroblastosis virus E26 oncogen homolog-1 (ETS-1) as mediator of the renal proinflammatory and profibrotic effects of angiotensin II.. 60. 2012
Association of pulse pressure with new-onset atrial fibrillation in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint (LIFE) reduction in hypertension study.. 60. 2012
Heme oxygenase gene targeting to adipocytes attenuates adiposity and vascular dysfunction in mice fed a high-fat diet.. 60. 2012
Recent trends in healthcare utilization among children and adolescents with hypertension in the United States.. 60. 2012
Endothelin 1-dependent neurovascular dysfunction in chronic intermittent hypoxia.. 60. 2012
Clinical significance of incident hypokalemia and hyperkalemia in treated hypertensive patients in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.. 59. 2012
Angiotensin II-dependent hypertension requires cyclooxygenase 1-derived prostaglandin E2 and EP1 receptor signaling in the subfornical organ of the brain.. 59. 2012
Angiogenic factors in superimposed preeclampsia: a longitudinal study of women with chronic hypertension during pregnancy.. 59. 2012
Vascular biomarkers in the prediction of clinical cardiovascular disease: the Strong Heart Study.. 59. 2011
Differential impacts of blood pressure and lipid lowering on regression of ventricular and arterial mass: the Stop Atherosclerosis in Native Diabetics Trial.. 58. 2011
Ethnic differences in arterial wave reflections and normative equations for augmentation index.. 57. 2011
Efficacy and duration of benazepril plus amlodipine or hydrochlorothiazide on 24-hour ambulatory systolic blood pressure control.. 57. 2010
Geographic and demographic variability in 20-year hypertension incidence: the CARDIA study.. 57. 2010
Adipocyte heme oxygenase-1 induction attenuates metabolic syndrome in both male and female obese mice.. 56. 2010
Cerebrovascular damage in late-life depression is associated with structural and functional abnormalities of subcutaneous small arteries.. 56. 2010
Does information on systolic and diastolic function improve prediction of a cardiovascular event by left ventricular hypertrophy in arterial hypertension?. 56. 2010
The transcription factor ETS-1 mediates proinflammatory responses and neointima formation in carotid artery endoluminal vascular injury.. 55. 2010
Cyclooxygenase 1-derived prostaglandin E2 and EP1 receptors are required for the cerebrovascular dysfunction induced by angiotensin II.. 55. 2010
Cardiovascular and metabolic predictors of progression of prehypertension into hypertension: the Strong Heart Study.. 54. 2009
Magnetic resonance imaging left ventricular mass reduction with fixed-dose angiotensin-converting enzyme inhibitor-based regimens in patients with high-risk hypertension.. 54. 2009
Estrous cycle-dependent neurovascular dysfunction induced by angiotensin II in the mouse neocortex.. 54. 2009
Eutrophic remodeling of small arteries in type 1 diabetes mellitus is enabled by metabolic control: a 10-year follow-up study.. 54. 2009
Heme oxygenase-1 induction remodels adipose tissue and improves insulin sensitivity in obesity-induced diabetic rats.. 53. 2009
Disparate estimates of hypertension control from ambulatory and clinic blood pressure measurements in hypertensive kidney disease.. 53. 2008
Marked regional left ventricular heterogeneity in hypertensive left ventricular hypertrophy patients: a losartan intervention for endpoint reduction in hypertension (LIFE) cardiovascular magnetic resonance and echocardiographic substudy.. 52. 2008
Serotonin 5-HT(2B) receptor blockade prevents reactive oxygen species-induced cardiac hypertrophy in mice.. 52. 2008
Gender differences in regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy.. 52. 2008
Effects of losartan in women with hypertension and left ventricular hypertrophy: results from the Losartan Intervention for Endpoint Reduction in Hypertension Study.. 51. 2008
Gender differences in left ventricular structure and function during antihypertensive treatment: the Losartan Intervention for Endpoint Reduction in Hypertension Study.. 51. 2008
Prevalence and correlates of left ventricular hypertrophy in the African American Study of Kidney Disease Cohort Study.. 50. 2007
In-treatment resolution or absence of electrocardiographic left ventricular hypertrophy is associated with decreased incidence of new-onset diabetes mellitus in hypertensive patients: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study.. 50. 2007
Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: the Strong Heart Study.. 50. 2007
Genetic variations associated with echocardiographic left ventricular traits in hypertensive blacks.. 49. 2007
Genome-wide linkage mapping for valve calcification susceptibility loci in hypertensive sibships: the Hypertension Genetic Epidemiology Network Study.. 49. 2007
Left atrial size and risk of major cardiovascular events during antihypertensive treatment: losartan intervention for endpoint reduction in hypertension trial.. 49. 2006
Nox2, Ca2+, and protein kinase C play a role in angiotensin II-induced free radical production in nucleus tractus solitarius.. 48. 2006
Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.. 48. 2006
A quantitative trait loci-specific gene-by-sex interaction on systolic blood pressure among American Indians: the Strong Heart Family Study.. 48. 2006
Association of hemoglobin delivery with left ventricular structure and function in hypertensive patients: Losartan Intervention for End Point Reduction in Hypertension Study.. 47. 2006
Prehypertension, diabetes, and cardiovascular disease risk in a population-based sample: the Strong Heart Study.. 47. 2006
A longitudinal study of hypertension risk factors and their relation to cardiovascular disease: the Strong Heart Study.. 47. 2006
Risk factors for arterial hypertension in adults with initial optimal blood pressure: the Strong Heart Study.. 47. 2005
Reduced NAD(P)H oxidase in low renin hypertension: link among angiotensin II, atherogenesis, and blood pressure.. 47. 2005
A population association study of angiotensinogen polymorphisms and haplotypes with left ventricular phenotypes.. 46. 2005
Differential effects of beta-blockers on albuminuria in patients with type 2 diabetes.. 46. 2005
Cardiovascular morbidity and mortality in hypertensive patients with lower versus higher risk: a LIFE substudy.. 46. 2005
Arterial stiffness in chronic inflammatory diseases.. 46. 2005
Pulse pressure and effects of losartan or atenolol in patients with hypertension and left ventricular hypertrophy.. 45. 2005
Is high pulse pressure a marker of preclinical cardiovascular disease?. 45. 2005
Association of blood pressure with blood viscosity in american indians: the Strong Heart Study.. 45. 2005
Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for endpoint reduction in hypertension study.. 45. 2005
Effects of angiotensin type-1 receptor antagonism on small artery function in patients with type 2 diabetes mellitus.. 45. 2005
Stroke reduction in hypertensive adults with cardiac hypertrophy randomized to losartan versus atenolol: the Losartan Intervention For Endpoint reduction in hypertension study.. 45. 2004
Evaluation of concentric left ventricular geometry in humans: evidence for age-related systematic underestimation.. 45. 2004
Atorvastatin prevents end-organ injury in salt-sensitive hypertension: role of eNOS and oxidant stress.. 44. 2004
Electrocardiographic strain pattern and prediction of cardiovascular morbidity and mortality in hypertensive patients.. 44. 2004
Differences in left ventricular structure between black and white hypertensive adults: the Hypertension Genetic Epidemiology Network study.. 43. 2004
Glucose-cholesterol interaction magnifies coronary heart disease risk for hypertensive patients.. 43. 2004
QRS duration and QT interval predict mortality in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention for Endpoint Reduction in Hypertension Study.. 43. 2004
Combined echocardiographic left ventricular hypertrophy and electrocardiographic ST depression improve prediction of mortality in American Indians: the Strong Heart Study.. 43. 2004
Cardiovascular risk factors and sequelae in hypertensive children identified by referral versus school-based screening.. 43. 2004
In salt-sensitive hypertension, increased superoxide production is linked to functional upregulation of angiotensin II.. 42. 2003
Coronary vasodilator capacity and hypertension-induced increase in left ventricular mass.. 41. 2003
Echocardiographic wall motion abnormalities in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE Study.. 41. 2003
Prognosis of inappropriate left ventricular mass in hypertension: the MAVI Study.. 40. 2002
Sibling resemblance for left ventricular structure, contractility, and diastolic filling.. 40. 2002
Correlates of left atrial size in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study.. 39. 2002
Cardiac and vascular remodeling in older adults with borderline isolated systolic hypertension: the ICARe Dicomano Study.. 38. 2001
Fibrinogen and preclinical echocardiographic target organ damage: the strong heart study.. 38. 2001
Effects of the reactive oxygen species hydrogen peroxide and hypochlorite on endothelial nitric oxide production.. 38. 2001
Linkage of left ventricular contractility to chromosome 11 in humans: The HyperGEN Study.. 38. 2001
Left ventricular systolic dysfunction in a biracial sample of hypertensive adults: The Hypertension Genetic Epidemiology Network (HyperGEN) Study.. 38. 2001
Relationship between left ventricular diastolic relaxation and systolic function in hypertension: The Hypertension Genetic Epidemiology Network (HyperGEN) Study.. 38. 2001
Human heme oxygenase-1 gene transfer lowers blood pressure and promotes growth in spontaneously hypertensive rats.. 38. 2001
6-[18F]fluorodopamine positron emission tomographic (PET) scanning for diagnostic localization of pheochromocytoma.. 38. 2001
Relation of age to left ventricular function and systemic hemodynamics in uncomplicated mild hypertension.. 37. 2001
Aortic root dilatation at sinuses of valsalva and aortic regurgitation in hypertensive and normotensive subjects: The Hypertension Genetic Epidemiology Network Study .. 37. 2001
Familial factors of blood pressure and adiposity covariation.. 37. 2001
Baseline Characteristics of Participants in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).. 37. 2001
Baseline characteristics in relation to electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan intervention for endpoint reduction (LIFE) in hypertension study. The Life Study Investigators.. 36. 2000
Angiotensin II-induced hypertension: contribution of Ras GTPase/Mitogen-activated protein kinase and cytochrome P450 metabolites.. 36. 2000
Impact of arterial stiffening on left ventricular structure.. 36. 2000
Contribution of Ras GTPase/MAP kinase and cytochrome P450 metabolites to deoxycorticosterone-salt-induced hypertension.. 35. 2000
Effect of obesity on electrocardiographic left ventricular hypertrophy in hypertensive patients : the losartan intervention for endpoint (LIFE) reduction in hypertension study.. 35. 2000
Impact of different partition values on prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population : the LIFE study.. 35. 2000
Ambulatory blood pressure and metabolic abnormalities in hypertensive subjects with inappropriately high left ventricular mass.. 34. 1999
Effects of L-arginine on atherogenesis and endothelial dysfunction due to secondhand smoke.. 34. 1999
Serum uric acid and cardiovascular events in successfully treated hypertensive patients.. 34. 1999
Diabetes and cardiovascular events in hypertensive patients.. 33. 1999
Assessment of arterial compliance by carotid midwall strain-stress relation in hypertension.. 33. 1999
Assessment of arterial compliance by carotid midwall strain-stress relation in normotensive adults.. 33. 1999
Stroke volume/pulse pressure ratio and cardiovascular risk in arterial hypertension.. 33. 1999
Handling 22NaCl by the blood-brain barrier and kidney: its relevance to salt-induced hypertension in dahl rats.. 33. 1999
TGF-beta1 DNA polymorphisms, protein levels, and blood pressure.. 33. 1999
Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Reduction in Hypertension.. 32. 1998
Impact of shift work and race/ethnicity on the diurnal rhythm of blood pressure and catecholamines.. 32. 1998
Interaction between body size and cardiac workload: influence on left ventricular mass during body growth and adulthood.. 31. 1998
Relation of left ventricular midwall function to cardiovascular risk factors and arterial structure and function.. 31. 1998
Time-voltage QRS area of the 12-lead electrocardiogram: detection of left ventricular hypertrophy.. 31. 1998
Relation of exercise-induced myocardial ischemia to cardiac and carotid structure.. 30. 1997
Relations of left ventricular geometry and function to body composition in children with high casual blood pressure.. 30. 1997
Age-related changes in total arterial capacitance from birth to maturity in a normotensive population.. 29. 1997
Confirmation or exclusion of stage I hypertension by ambulatory blood pressure monitoring.. 29. 1997
Left ventricular filling in arterial hypertension. Influence of obesity and hemodynamic and structural confounders.. 29. 1997
Hypertension in adult American Indians. The Strong Heart Study.. 28. 1996
Influence of obesity on left ventricular midwall mechanics in arterial hypertension.. 28. 1996
Association of carotid atherosclerosis with electrocardiographic myocardial ischemia and left ventricular hypertrophy.. 28. 1996
Effect of hypertension on aortic root size and prevalence of aortic regurgitation.. 28. 1996
Correlations of Na+-Li+ exchange activity with Na+ and Li+ binding and phospholipid composition in erythrocyte membranes of white hypertensive and normotensive individuals: a nuclear magnetic resonance investigation.. 27. 1996
Time-voltage area of the QRS for the identification of left ventricular hypertrophy.. 27. 1996
Gender differences in left ventricular growth.. 26. 1995
Is white coat hypertension associated with arterial disease or left ventricular hypertrophy?. 26. 1995
Isolated diastolic hypertension. A favorable finding among young and middle-aged hypertensive subjects.. 26. 1995
Isolated elevation of diastolic blood pressure. Real or artifactual?. 26. 1995
Prevalence and determinants of cardiac and vascular hypertrophy in hypertension.. 26. 1995
Low urinary sodium is associated with greater risk of myocardial infarction among treated hypertensive men.. 25. 1995
Gender differences and the electrocardiogram in left ventricular hypertrophy.. 25. 1995
Relationships among plasma aldosterone, high-density lipoprotein cholesterol, and insulin in humans.. 25. 1995
Confirmation of mutant alpha 1 Na,K-ATPase gene and transcript in Dahl salt-sensitive/JR rats.. 24. 1994
How should diastolic blood pressure be defined during pregnancy?. 24. 1994
Relation of obesity and gender to left ventricular hypertrophy in normotensive and hypertensive adults.. 23. 1994
Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction.. 23. 1994
Nitric oxide mediates immune dysfunction in the spontaneously hypertensive rat.. 21. 1993
Effects of angiotensin converting enzyme inhibition with cilazapril on intimal hyperplasia in injured arteries and vascular grafts in the baboon.. 18. 1991
Cellular ions in hypertension, diabetes, and obesity. A nuclear magnetic resonance spectroscopic study.. 17. 1991
Characterization of auscultatory gaps with wideband external pulse recording.. 17. 1991
Prevention of hypertension and vascular changes by captopril treatment.. 17. 1991
Dietary salt and blood pressure. A perspective.. 17. 1991
Body fat and its distribution in relation to casual and ambulatory blood pressure.. 15. 1990
Relation of plasma renin to end organ damage and to protection of K+ feeding in stroke-prone hypertensive rats.. 15. 1990
Renal functional reserve and microalbuminuria in offspring of hypertensive parents.. 15. 1990
Impact of race on treatment response and cardiovascular disease among hypertensives.. 14. 1989
Diagnosis ex juvantibus. Individual response patterns to drugs reveal hypertension mechanisms and simplify treatment.. 12. 1988
Effect of vasopressors on atrial natriuretic factor and hemodynamic function in humans.. 12. 1988
Supernormal contractility in primary hypertension without left ventricular hypertrophy.. 11. 1988
Prevalence of drug resistant hypertension.. 11. 1988
Calcium in the regulation of aldosterone secretion and vascular smooth muscle contraction.. 10. 1987
Structural and functional consequence of neonatal sympathectomy on the blood vessels of spontaneously hypertensive rats.. 10. 1987
Cost-effectiveness of echocardiography and electrocardiography for detection of left ventricular hypertrophy in patients with systemic hypertension.. 9. 1987
Hypertension research. Echocardiography in the measurement of left ventricular wall mass.. 9. 1987
Recommendations concerning use of echocardiography in hypertension and general population research.. 9. 1987
Cardiovascular effects of atrial natriuretic factor in anesthetized and conscious dogs.. 8. 1986
Effect of atrial natriuretic factor on blood pressure, renin, and aldosterone in Goldblatt hypertension.. 7. 1985
Partial deficiency of adrenal 11-hydroxylase. A possible cause of primary hypertension.. 7. 1985
Increased cardiac performance in mild essential hypertension. Left ventricular mechanics.. 7. 1985
What is the role of ambulatory blood pressure monitoring in the management of hypertensive patients?. 7. 1985
Blood pressure, lanthanum-, and norepinephrine-induced mechanical response in thoracic aortic tissue.. 6. 1984
Left ventricular mass reduction during salt depletion in arterial hypertension.. 6. 1984
Molecular biology of adrenergic receptors in the rat and frog central nervous system.. 6. 1984
Atrial natriuretic factor inhibits angiotensin-, norepinephrine-, and potassium-induced vascular contractility.. 6. 1984
Evidence that disruption of the blood-brain barrier precedes reduction in cerebral blood flow in hypertensive encephalopathy.. 6. 1984
What is the value of home blood pressure measurement in patients with mild hypertension?. 6. 1984
Reduction of cardiovascular disease events by worksite hypertension treatment.. 5. 1983
Left ventricular hypertrophy and function in high, normal, and low-renin forms of essential hypertension.. 4. 1982
Profile of hypertensives as a determinant of long-term antihypertensive medication needs.. 3. 1981
Management of the hypertensive patient: a continuing dilemma.. 3. 1981
Response to should more significance be granted to medication response to antihypertensives in patients with resistant hypertension?. 63. 2014
Response to are observational studies more informative than randomized controlled trials in hypertension? Con side of the argument.. 62. 2013
"Effective" plasma renin activity: a derived measure for assessing residual plasma renin activity in patients taking angiotensin-converting enzyme inhibitors or angiotensin receptor blockers.. 55. 2010
Method errors or unexplained biological information? 2010
Questions regarding the aortic measurements of Mitchell et al. 2008
Reduction of blood pressure levels study group. 2006
Pulse pressure and antihypertensive agents. 2005
What is bright is not always gold. 2003
Central blood pressure measurements and antihypertensive therapy: a consensus document. 2007
A consensus view on the technique of ambulatory blood pressure monitoring. The Fourth International Consensus Conference on 24-Hour Ambulatory Blood Pressure Monitoring. 1995
Cardiac and arterial hypertrophy and atherosclerosis in hypertension. 1994
Time in Target Blood Pressure Range and Dementia.. 80. 2023
Are Financial Incentives for Patients an Effective Treatment for Hypertension Attention-Deficit Disorder?. 79. 2022
Blood-Brain Barrier Crossing Renin-Angiotensin System Drugs: Considerations for Dementia and Cognitive Decline.. 78. 2021
Incremental Value of Echocardiography in Patients With or Without Hypertension: Which (Death)Star to Hitch the Wagon?. 71. 2018
Mechanism of heme-heme oxygenase system impairment of endothelium contraction in the spontaneously hypertensive rat.. 58. 2011
Assessing left ventricular performance: a rashomon effect.. 51. 2007
Morbid obesity and left ventricular geometry.. 49. 2006
Left ventricular hypertrophy in blacks and whites: different genes or different exposure?. 46. 2005
Concentric or eccentric hypertrophy: how clinically relevant is the difference?. 43. 2004
Animal Models of Hypertension: A Scientific Statement From the American Heart Association. 2019
Hypertension in HIV-Infected Adults: Novel Pathophysiologic Mechanisms. 2018
Introduction to the American Heart Association's Hypertension Strategically Focused Research Network. 2016
Hypertension: a harbinger of stroke and dementia. 2013
Role of pulse pressure amplification in arterial hypertension: experts' opinion and review of the data. 2009
Update on the use of antihypertensive drugs in pregnancy. 2008
Maintaining equilibrium by selective targeting of cyclooxygenase pathways: promising offensives against vascular injury. 2007
Hypertension, Neurodegeneration, and Cognitive Decline. 2024
Appraising the Preclinical Evidence of the Role of the Renin-Angiotensin-Aldosterone System in Antenatal Programming of Maternal and Offspring Cardiovascular Health Across the Life Course: Moving the Field Forward: A Scientific Statement From the American Heart Association. 2023
Dyslipidemia and Risk of Preeclampsia: A Multiancestry Mendelian Randomization Study. 2023
Hypertension, Neurovascular Dysfunction, and Cognitive Impairment. 2022
Emerging Viral Infections, Hypertension, and Cardiovascular Disease in Sub-Saharan Africa: A Narrative Review. 2022
Medical Therapies for Heart Failure With Preserved Ejection Fraction. 2019
Association of central and peripheral blood pressures with intermediate cardiovascular phenotypes. 2014
Detection of left ventricular hypertrophy by M-mode echocardiography. Anatomic validation, standardization, and comparison to other methods. 1987
Left ventricular hypertrophy in hypertension. Prevalence and relationship to pathophysiologic variables. 1987
Reproducibility of echocardiographic left ventricular measurements. 1987

VIVO Weill Cornell Medical College

Hypertension (Dallas, Tex. : 1979) Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)